Sonic Healthcare Limited

Sonic Healthcare Limited

11.94
EUR
-0.18
(-1.52%)
0.63EPS
25.04P/E
7.18BMarket Cap
Feb 22Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
8.67
9.63
10.32
12.05
12.13
12.97
13.54
14.28
18.33
19.49
17.34
18.77
20.03
Basic EPS, GAAP
0.85
0.96
0.9
1.1
1.03
1.13
1.22
1.11
2.75
3.05
1.46
1.07
1.07
Free Cash Flow per Basic Share
0.58
0.84
0.62
0.76
0.79
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.52
0.65
0.7
0.53
0.68
0.57
0.83
0.87
0.89
0.98
1.04
1.17
1.18
Book Value per Share
7.29
7.69
8.18
8.82
9.14
9.84
11.42
11.73
13.36
15.42
16.43
16.48
17.33
Tangible Book Value per Share
-12
-2.5
-13.27
-15.39
-3.7
-3.64
-16.47
-16.84
-14
-15
-15.77
-20.29
-3
Basic Weighted Avg Shares
395
400
401
410
417
422
449
475
477
478
470
476
480
Sales/Revenue/Turnover
3,425
3,855
4,141
4,947
5,054
5,476
6,076
6,783
8,753
9,321
8,145
8,934
9,619
Operating Margin (%)
13.12
13.47
11.16
11.31
11.39
11.51
11.52
11.24
21.93
22.93
12.21
9.14
9.41
Depreciation Expense
141
161
179
220
228
256
273
606
642
675
703
777
815
Net Income, GAAP
335
385
363
451
428
476
550
528
1,315
1,461
685
511
514
Effective Tax Rate (%)
23.37
24.49
23.88
22.03
23.16
21.38
22.59
22.48
26.3
27.04
23.98
25.57
27.56
Profit Margin (%)
9.78
9.99
8.77
9.12
8.46
8.69
9.05
7.78
15.02
15.67
8.41
5.72
5.34
Working Capital
-927
-108
208
-834
-311
-58
-1,415
-658
-1,144
-677
-598
-621
382
LT Debt
2,874
1,521
4,448
4,197
2,052
5,583
4,418
6,825
4,276
4,248
4,427
6,545
4,710
Total Equity
2,918
3,109
3,342
3,733
3,926
4,283
5,492
5,664
6,504
7,428
7,922
8,075
8,473
Return on Invested Capital (%)
5.3
6.54
5.44
5.22
5.6
5.89
5
4.66
11.11
12.88
5.97
4.31
4.52
Return on Capital (%)
5.89
7.17
6.21
5.87
5.94
6.33
5.66
4.79
10.77
12.42
5.89
4.23
3.94
Return on Common Equity (%)
12.22
12.88
11.4
12.98
11.42
11.88
11.46
9.61
21.99
21.39
9.13
6.53
6.32

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.99%
8.51%
4.93%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
12.4%
16.45%
0.49%
Sales/Revenue/Turnover
9.28%
8.06%
7.67%
Total Cash Common Dividend
9.09%
6.68%
1.33%

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
8,145
2024
- -
- -
8,934
2025
- -
- -
9,619

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.46
2024
- -
- -
1.07
2025
- -
- -
1.07

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.04
2024
- -
- -
1.17
2025
- -
- -
1.18

Company Description

CEO
Jim Newcombe
Full Time Employees
49,000
Sector
Health services
Industry
Medical/Nursing services
Address
Grosvenor Place Sydney NSW Australia 2000
IPO Date
Sep 25, 1934
Business
Sonic Healthcare Limited (ASX: SHL), headquartered in Sydney, Australia, and founded in 1987, ranks as one of the world's leading providers of medical diagnostic services, including pathology and clinical laboratory testing in disciplines such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology and molecular pathology; radiology and diagnostic imaging services; primary care through medical centres; and occupational health services. The company operates across Australia, New Zealand, the United States, the United Kingdom, Germany, Switzerland, Belgium and Ireland, where it holds the largest private pathology position in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third-largest in the US, employing approximately 45,000 people including 1,600 pathologists and radiologists. Sonic recently completed acquisitions in Germany, Switzerland, the UK and the US that contribute about A$700 million in additional annual revenue from FY25 alongside new contract wins, driving projected EBITDA growth to A$1.7-A$1.75 billion in FY25 and further margin expansion in FY26; reported FY25 revenue of A$9.6 billion and net profit of A$514 million; and announced Dr. Jim Newcombe as incoming CEO and Managing Director effective 20 November 2025, succeeding Dr. Colin Goldschmidt.

Company News

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Down – Here’s Why

  • Sonic Healthcare (OTCMKTS:SKHHY) Sets New 12-Month Low – Time to Sell?

  • Sonic Healthcare Limited (OTCMKTS:SKHCF) Short Interest Down 35.0% in August

  • Critical Contrast: Ethema Health (OTCMKTS:GRST) & Sonic Healthcare (OTCMKTS:SKHHY)

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Pass Below 200 Day Moving Average – Here’s What Happened

  • CochLear (OTCMKTS:CHEOY) and Sonic Healthcare (OTCMKTS:SKHHY) Financial Review

  • Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF) Critical Survey

  • Sonic Healthcare Limited (SKHHY) Q2 2026 Earnings Call Transcript

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Up – Time to Buy?

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Down – Should You Sell?

  • Sonic Healthcare Limited (SKHHY) Shareholder/Analyst Call Transcript

  • Comparing Sonic Healthcare (OTCMKTS:SKHHY) & InnovAge (NASDAQ:INNV)

  • All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy

  • Sonic Healthcare Limited (SKHCF) Q4 2025 Earnings Call Transcript

  • Sonic Healthcare Limited (SKHCF) Q2 2025 Earnings Call Transcript

  • Sonic Healthcare Limited (SKHCF) Q2 2024 Earnings Call Transcript